MediciNova

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.12-$2.55
Market Cap
$76.5M
Shares Short
231,519

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$0
Diluted EPS
-$0.23

News

See more

Yahoo Finance • 13 days ago

MediciNova To Participate in D. Boral’s Capital Global Conference on May 14, 2025

Yahoo Finance • 19 days ago

First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients

Yahoo Finance • last year

MediciNova Announces New Data and Results of a Phase 2 Clinical Trial of MN-166 (ibudilast) in Glioblastoma Presented at the 28th Annual Meeting of the Society for Neuro-Oncology

Yahoo Finance • 2 years ago

MediciNova’s Collaborator Initiates Clinical Development of a Gene Therapy Product for the Treatment of Phenylketonuria

About

CEO
Dr. Yuichi Iwaki M.D., Ph.D.
CFO
Mr. Jason J. Kruger CPA
Address
4275 Executive Square, La Jolla, CA, United States, 92037
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
13